Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
Phase II study of irinotecan plus cisplatin in patients with advanced non-small-cell lung cancer. [electronic resource] by
- DeVore, R F
- Johnson, D H
- Crawford, J
- Garst, J
- Dimery, I W
- Eckardt, J
- Eckhardt, S G
- Elfring, G L
- Schaaf, L J
- Hanover, C K
- Miller, L L
Producer: 20000105
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 17
Availability: No items available.
|
|
15.
|
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. [electronic resource] by
- Saltz, L B
- Cox, J V
- Blanke, C
- Rosen, L S
- Fehrenbacher, L
- Moore, M J
- Maroun, J A
- Ackland, S P
- Locker, P K
- Pirotta, N
- Elfring, G L
- Miller, L L
Producer: 20000928
In:
The New England journal of medicine vol. 343
Availability: No items available.
|
|
16.
|
Phase I clinical and pharmacologic study of weekly cisplatin combined with weekly irinotecan in patients with advanced solid tumors. [electronic resource] by
- Saltz, L B
- Spriggs, D
- Schaaf, L J
- Schwartz, G K
- Ilson, D
- Kemeny, N
- Kanowitz, J
- Steger, C
- Eng, M
- Albanese, P
- Semple, D
- Hanover, C K
- Elfring, G L
- Miller, L L
- Kelsen, D
Producer: 19990105
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 16
Availability: No items available.
|
|
17.
|
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancy. [electronic resource] by
- Pitot, H C
- Goldberg, R M
- Reid, J M
- Sloan, J A
- Skaff, P A
- Erlichman, C
- Rubin, J
- Burch, P A
- Adjei, A A
- Alberts, S A
- Schaaf, L J
- Elfring, G
- Miller, L L
Producer: 20001207
In:
Clinical cancer research : an official journal of the American Association for Cancer Research vol. 6
Availability: No items available.
|
|
18.
|
A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma. [electronic resource] by
- Rothenberg, M L
- Cox, J V
- DeVore, R F
- Hainsworth, J D
- Pazdur, R
- Rivkin, S E
- Macdonald, J S
- Geyer, C E
- Sandbach, J
- Wolf, D L
- Mohrland, J S
- Elfring, G L
- Miller, L L
- Von Hoff, D D
Producer: 19990329
In:
Cancer vol. 85
Availability: No items available.
|
|
19.
|
Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer. [electronic resource] by
- Rothenberg, M L
- Eckardt, J R
- Kuhn, J G
- Burris, H A
- Nelson, J
- Hilsenbeck, S G
- Rodriguez, G I
- Thurman, A M
- Smith, L S
- Eckhardt, S G
- Weiss, G R
- Elfring, G L
- Rinaldi, D A
- Schaaf, L J
- Von Hoff, D D
Producer: 19960725
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 14
Availability: No items available.
|
|
20.
|
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks. [electronic resource] by
- Rothenberg, M L
- Kuhn, J G
- Schaaf, L J
- Rodriguez, G I
- Eckhardt, S G
- Villalona-Calero, M A
- Rinaldi, D A
- Hammond, L A
- Hodges, S
- Sharma, A
- Elfring, G L
- Petit, R G
- Locker, P K
- Miller, L L
- von Hoff, D D
Producer: 20020716
In:
Annals of oncology : official journal of the European Society for Medical Oncology vol. 12
Availability: No items available.
|